… For 2 patients, there were no available data on symptoms. None of the 9 infants required … -19 were not reported in the age range of 0 to 9 years. One death was reported in the age range …
… act [95% CI 0·3–8·9]). Estimates for the early and late phases of HIV infection were 9·2 (95% CI 4·5–18·8) and 7·3 (95% CI 4·5–11·9) times larger, respectively, than for the asymptomatic …
… The ratio of male to female cases among living cases resembled [2], at 58%, with most 30–59 years of age (information missing for 9 cases). The deceased cases were more …
… Global mean(95%CI) CKD prevalence of 5 stages 13·4%(11·7–15·1%), and stages 3–5 was 10·6%(9·2–12·2%). Weighting by study quality did not affect prevalence estimates. CKD …
… COX-1 and COX-2 are coded by 2 distinct genes located on human chromosome 9 and 1, respectively. The COX-2 gene is characterized by the presence of a TATA box and a multitude …
… data for protons on Cu at 9.MeU have been extensively analyzed to determine the best … a ratio of surface-tovolume imaginary potential of at least 2 to 1.Hodgson, " however, analyzing …
… interval [UI] 59·5–105·9) to 125·3 million (93·0–163·2), and the proportion of global DALYs attributed to mental disorders increased from 3·1% (95% UI 2·4–3·9) to 4·9% (3·9–6·1). Age-…
… The BMI categories used were less than 32 kg/m 2 and 32 kg/m 2 or greater in REWIND, and less than median 31·9 kg/m 2 and median 31·9 kg/m 2 or greater in AMPLITUDE-O. ¶The …
… Median progression-free survival was 9·2 months (95% CI 8·0–13·9) in the gefitinib group and 6·3 months (5·8–7·8) in the cisplatin plus docetaxel group (p<0·0001; figure 2A). Gefitinib …
… 9 ± 2 kcallmol. The absence of an observed triplet state in the CF2- photoelectron spectrum allows us to assign a lower bound on the triplet excitation energy of CF2 of 50 ± 2 kcallmol. …